See more : Dangee Dums Limited (DANGEE.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Berkeley Lights, Inc. (BLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Berkeley Lights, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Sharp Corporation (SHCAF) Income Statement Analysis – Financial Results
- Tryp Therapeutics Inc. (TRYPF) Income Statement Analysis – Financial Results
- MDEChem, Inc. (MDKM) Income Statement Analysis – Financial Results
- Sky Gold Corp. (SRKZF) Income Statement Analysis – Financial Results
- Shenzhen Yanmade Technology Inc. (688312.SS) Income Statement Analysis – Financial Results
Berkeley Lights, Inc. (BLI)
About Berkeley Lights, Inc.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 78.60M | 85.39M | 64.30M | 56.69M | 31.30M |
| Cost of Revenue | 24.81M | 28.84M | 19.75M | 13.22M | 8.18M |
| Gross Profit | 53.78M | 56.55M | 44.56M | 43.48M | 23.12M |
| Gross Profit Ratio | 68.43% | 66.23% | 69.29% | 76.69% | 73.86% |
| Research & Development | 53.21M | 58.55M | 47.24M | 38.41M | 29.08M |
| General & Administrative | 0.00 | 43.40M | 23.20M | 12.36M | 9.07M |
| Selling & Marketing | 0.00 | 25.39M | 14.51M | 9.24M | 6.13M |
| SG&A | 95.12M | 68.79M | 37.71M | 21.60M | 15.20M |
| Other Expenses | -246.00K | 6.00K | 82.00K | -1.18M | 0.00 |
| Operating Expenses | 148.32M | 127.34M | 84.95M | 60.01M | 44.28M |
| Cost & Expenses | 173.14M | 156.18M | 104.70M | 73.23M | 52.46M |
| Interest Income | 1.27M | 175.00K | 338.00K | 909.00K | 872.00K |
| Interest Expense | 910.00K | 1.17M | 1.44M | 1.43M | 2.20M |
| Depreciation & Amortization | 1.02M | 181.00K | 420.00K | 6.24M | 4.29M |
| EBITDA | -93.52M | -70.61M | -39.97M | -10.29M | -16.87M |
| EBITDA Ratio | -118.99% | -82.69% | -62.17% | -18.16% | -53.89% |
| Operating Income | -94.54M | -70.79M | -40.39M | -16.54M | -21.16M |
| Operating Income Ratio | -120.29% | -82.90% | -62.82% | -29.17% | -67.60% |
| Total Other Income/Expenses | -3.40M | -990.00K | -1.02M | -1.70M | -2.11M |
| Income Before Tax | -97.94M | -71.78M | -41.41M | -18.23M | -23.27M |
| Income Before Tax Ratio | -124.61% | -84.06% | -64.40% | -32.16% | -74.34% |
| Income Tax Expense | 100.00K | -55.00K | 174.00K | 69.00K | 69.00K |
| Net Income | -98.04M | -71.72M | -41.58M | -18.30M | -23.34M |
| Net Income Ratio | -124.74% | -84.00% | -64.67% | -32.28% | -74.56% |
| EPS | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
| EPS Diluted | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
| Weighted Avg Shares Out | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
| Weighted Avg Shares Out (Dil) | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif. , March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq:...
Berkeley Lights, Inc. (BLI) Q4 2022 Earnings Call Transcript
Berkeley Lights, Inc. (NASDAQ:BLI ) Q4 2022 Results Conference Call February 23, 2023 4:30 PM ET Company Participants Suzanne Hatcher - VP, Communications and IR Dr. Siddhartha Kadia - CEO Mehul Joshi - CFO Conference Call Participants Chad Wiatrowski -...
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
EMERYVILLE, Calif. , Feb. 23, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IsoPlexis Corporation (NasdaqGS: ISO) to Berkeley Lights, Inc. (NasdaqGS: BLI). Under...
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
EMERYVILLE, Calif. , Feb. 13, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Berkeley Lights, Inc. (BLI) and Encourages Long-Term BLI Investors to Contact the Firm
Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2023) - Kaskela Law LLC announces that it is investigating Berkeley Lights, Inc. (NASDAQ: BLI) on behalf of the company's long-term investors.Recently a securities fraud complaint was filed against Berkeley Lights on behalf of...
SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation
NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IsoPlexis Corporation ("IsoPlexis" or the "Company") (NASDAQ: ISO) in connection with its proposed acquisition...
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
EMERYVILLE, Calif. , Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended December 31, 2022.
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications EMERYVILLE, Calif. , Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life...
Berkeley Lights Generates Further Losses Amid Merger Plan
Berkeley Lights, Inc. went public in July 2020, raising around $178 million in an IPO. The firm recently announced a merger with IsoPlexis Corporation, with the combined entity to be renamed PhenomeX.
Source: https://incomestatements.info
Category: Stock Reports